Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders
The past two decades have seen a tremendous growth in knowledge related to cannabinoid receptor signaling in brain. In addition, the impact and consequences of cannabinoid modulation of monoaminergic circuits is steadily emerging demonstrating a significant interaction between these two systems in a...
| Other Authors: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
New York, NY
Springer New York
2013, 2013
|
| Edition: | 1st ed. 2013 |
| Subjects: | |
| Online Access: | |
| Collection: | Springer eBooks 2005- - Collection details see MPG.ReNa |
Table of Contents:
- Endocannabinoids and monoamines: modulating the modulators
- Endocannabinoid-mediated synaptic plasticity
- Current cannabinoid receptor nomenclature and pharmacological principles
- Cue-elicited craving for cannabis activates the reward neurocircuitry associated with the neuropathology of addiction
- Cannabinoid modulation of dopaminergic circuits in neurodegenerative and neuropsychiatric disorders
- Pathophysiology of mood disorders and mechanisms of action of antidepressants and mood stabilizers
- Anatomical, biochemical and behavioral evidence for cannabinoid modulation of noradrenergic circuits: role of norepinephrine in cannabinoid-induced aversion
- Gender Disparity of Depression: The Role of Endocannabinoids and Noradrenergic Function
- Endocannabinoids, Monoamines and Stress
- Chronic effects of cannabinoid drugs on monoaminergic systems and the role of endocannabinoids and cannabinoid receptors in human brain disorders
- Endocannabinoid Signaling and the Regulation of theSerotonin System
- Modulation of serotonin firing activity through CB1 agonists and FAAH inhibitors
- Involvement of serotonergic system in cannabinoid analgesia
- Cannabinoids, monoamines, COMT and schizophrenia: pathobiological mechanisms in psychosis